Rezultati - Gregory D. Busse

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

    A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hypera... od Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Fatima Chowdhry, Gregory D. Busse, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder

    A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder od Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Gregory D. Busse, Fatima Chowdhry, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial

    Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial od Jenny Downs, Peter Jacoby, Nicola Specchio, H Cross, S Amin, Nadia Bahi‐Buisson, Rajsekar R. Rajaraman, Bernhard Suter, Orrin Devinsky, A Aimetti, Gregory D. Busse, Heather E. Olson, S Demarest, T A Benke, E Pestana-Knight

    Izdano 2024
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: